You
are aware that cancer is the second most deadly disease killing thousands of people daily. As cancer is a complex disease application of
high throughput genomics methods opens up new avenues for understanding and treating
the disease. Cancer genomics programme
is moving to the next level because
of the initiatives made by Cancer Moonshot Programme (Click here to read more about Cancer
Moon Shot Programme). As part of the US-Cancer
Moonshot and the US-President’s Precision Medicine Initiative, Foundation
Medicine is more than doubling the total number of patients represented within
the NCI's Genomic Data Commons (GDC),
bringing its total to over 32,000 patients
accumulated in just over a month. At its launch in early June, the GDC already
shared more than five petabytes of raw unprocessed genomic data from large
research projects on nearly thirty tumor types from more than 14,000 patients,
along with associated clinical data (e.g. clinical diagnosis, treatment
history, survival data), creating a foundational system for broad sharing and
analysis of cancer genomic data, which is critical for advancing the field of
precision medicine and improving the care of cancer patients.
